Karuna Therapeutics and Bristol Myers Squibb are winners of the 2025 Gizmodo Science Fair for their research and development of Cobenfy (xanomeline-trospium), the first truly novel medication for ...

Credit: Getty Images A literature review of nonpharmacologic treatments for patients with schizophrenia and comparison recommendations in the 2020 American Psychiatric Association Practice (APA) ...

For Henry Cockburn, the onset of schizophrenia felt like pure common sense. It was February 2002, and the 20-year-old art student had strayed from the University of Brighton to satisfy his desire for ...

A novel drug, evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social interaction, and dopamine balance, offering hope for tackling symptoms that ...

CT-155 (Boehringer Ingelheim and Click Therapeutics), an investigational prescription digital therapeutic, was both safe and effective in reducing negative symptoms of schizophrenia in a new phase 3 ...

Schizophrenia is a chronic and severe neurological disorder which disorients an individual’s perception of reality. Consequently, this affects how patients think, feel, and behave. Currently, ...

Antibodies from llamas could be used to create a new generation of schizophrenia treatments that can effectively target the brain, rather than just reducing symptoms. This is the promise of a study ...

This retrospective case report presents the use of a carnivore ketogenic diet by a subject with schizophrenia, supported by a nutritional therapy practitioner, resulting in remission. The narrative ...

The actor opens up to PEOPLE about "getting over my fear" of his sister's lifelong mental health condition Michael Simon When Taye Diggs' sister was diagnosed with schizophrenia in her 20s, he admits, ...

Schizophrenia is a relatively rare but disabling psychotic disorder that affects less than 1% of people around the world. But schizophrenia is more common among refugee and immigrant populations. Does ...

"This is the first study in schizophrenia to link inflammation with both brain changes in reward circuits and specific motivational symptoms," says David Goldsmith, MD, associate professor in the ...